Sartorius Stedim Biotech stock trades at EUR 204.80 with EUR 19,933 million value
Published on 09/23/2026 at 17:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sartorius Stedim Biotech stock (ISIN FR0013154002) was trading at EUR 204.80 on Euronext Paris at 2:03 p.m. CET on September 23, 2026, down 0.78 percent from the previous close. The company had a market capitalization of EUR 19,933 million at the same point in the session, giving the valuation metric immediate weight alongside the modest daily decline.
First half shows higher revenue
The latest operating update covers the first half of 2026. According to Ideal Investisseur, Sartorius Stedim Biotech reported revenue of EUR 1,527 million for S1 2026, up 6.4 percent. EBITDA reached EUR 463.7 million, while the EBITDA margin stood at 31.4 percent.
Net income for the same period was EUR 181.1 million, according to Ideal Investisseur. The comparison between 6.4 percent revenue growth and the 31.4 percent margin shows why profitability remains central to the equity story.
Guidance keeps the range visible
For 2026, management continues to target revenue growth of 6 percent to 10 percent at constant exchange rates. The same report lists expected revenue of EUR 3,154 million and expected EBITDA of EUR 989.2 million, creating a clear full-year benchmark against the EUR 1,527 million first-half revenue base.
That relationship matters for the stock because the second half must deliver EUR 1,627 million of revenue to reach the cited full-year expectation. The calculation is a reference point, not a forecast, and it places execution in the remaining reporting periods at the center of the valuation discussion.
Stock valuation stays elevated
At EUR 204.80 on September 23, 2026, Sartorius Stedim Biotech stock was down 0.78 percent intraday, while the company was valued at EUR 19,933 million. The combination of 6.4 percent first-half revenue growth, a 31.4 percent EBITDA margin and the 2026 revenue range gives investors three measurable checkpoints for subsequent updates.
Sartorius Stedim Biotech key data
- Company: Sartorius Stedim Biotech S.A.
- ISIN: FR0013154002
- Ticker: DIM
- Trading venue: Euronext Paris
- Price as of September 23, 2026, 2:03 p.m. CET: EUR 204.80, down 0.78 percent
- Market capitalization: EUR 19,933 million as of September 23, 2026
- Sector / Industry: Healthcare / Medical equipment and supplies
- Index membership: SBF 120
